Antidepressant use and risk of recurrent stroke: A population-based nested case-control study

Journal of Clinical Psychiatry

Volumn 76, Issue 7, 2015, Pages e877-e885

  Wang, Meng Ting ^a   Chu, Che Li ^a   Yeh, Chin Bin ^b   Chang, Li Chien ^a   Malone, Daniel C ^c   Liou, Jun Ting ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MELITRACEN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PSYCHOTHERAPY; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; TAIWAN; TREATMENT DURATION; ADULT; CASE CONTROL STUDY; CHEMICALLY INDUCED; FACTUAL DATABASE; FOLLOW UP; MIDDLE AGED; PRESCRIPTION; RECURRENT DISEASE; RISK; STATISTICS AND NUMERICAL DATA; STROKE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK; SEROTONIN UPTAKE INHIBITORS; STROKE; TAIWAN;

EID: 84938064258     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.14m09134     Document Type: Article

References (49)

1. Dhamoon MS, Sciacca RR, Rundek T, et al. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology. 2006;66(5):641-646. doi:10.12/01wnl.20125.9381.f6 PubMed
2. Jørgensen HS, Nakayama H, Reith J, et al. Stroke recurrence: predictors, severity, and prognosis: the Copenhagen Stroke Study. Neurology. 1997;48(4):891-895. doi:10.12/WNL.484.891 PubMed
3. Burn J, Dennis M, Bamford J, et al. Long-term risk of recurrent stroke after a first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1994;25(2):333-337. doi:10.61/01STR.252.3 PubMed
4. Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat. 2008;4(1):145-154. doi:10.2147/NDT.S2017PubMed
5. Chemerinski E, Levine SR. Neuropsychiatric disorders following vascular brain injury. Mt Sinai J Med. 2006;73 (7):1006-1014. PubMed
6. Morris PL, Robinson RG, Samuels J. Depression, introversion and mortality following stroke. Aust N Z J Psychiatry. 1993;27(3):443-449. doi:10.319/004867939075801 PubMed
7. Miller EL, Murray L, Richards L, et al; American Heart Association Council on Cardiovascular Nursing and the Stroke Council. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke. 2010; 41(10): 2402-2448. doi:10.161/STR.b013e381e7512 PubMed
8. Duncan PW, Zorowitz R, Bates B, et al. Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke. 2005; 36(9): e100-e143. doi:10.16/01.STR.0086154180.FF PubMed
9. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med. 2009;169 (22): 2128-2139. doi:10.01/archintrnmed209.436 PubMed
10. Chen Y, Guo JJ, Li H, et al. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother. 2008;42(2):177-184. doi:10.1345/aph.1K369 PubMed
11. Trifirò G, Dieleman J, Sen EF, et al. Risk of ischemic stroke associated with antidepressant drug use in elderly persons. J Clin Psycho pharmacol. 2010;30(3):252-258. doi:10.1097/JCP.b013e381dc10a PubMed
12. Verdel BM, Souverein PC, Meenks SD, et al. Use of serotonergic drugs and the risk of bleeding. Clin Pharmacol Ther. 2011;89(1):89-96. doi:10.1038/clpt.201.240 PubMed
13. Wu CS, Wang SC, Cheng YC, et al. Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry. 2011;168 (5):511-521. doi:10.176/i.ajp20.171064 PubMed
14. Coupland C, Dhiman P, Morriss R, et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343(1):d4551. doi:10.136/bmj.d451 PubMed
15. de Abajo FJ, Jick H, Derby L, et al. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol. 2000;50(1):43-47. doi:10.104/j.1365-15.2.0216.x PubMed
16. Douglas I, Smeeth L, Irvine D. The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol. 2011;71(1):116-120. doi:10.1111/j.1365-25.201.0397.x PubMed
17. Bak S, Tsiropoulos I, Kjaersgaard JO, et al. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke. 2002;33(6):1465-1473. doi:10.16/01.STR.00000189.5691.BA PubMed
18. Kharofa J, Sekar P, Haverbusch M, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke. 2007;38(11):3049-3051. doi:10.61/STROKEHA.10.91472 PubMed
19. Mortensen JK, Larsson H, Johnsen SP, et al. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke. 2013;44(2):420-426. doi:10.61/STROKEAHA12.6742 PubMed
20. Chen YC, Yeh HY, Wu JC, et al. Taiwan's national health insurance research database: administrative health care database as study object in bibliometrics. Scientometrics. 2011;86(2):365-380. doi:10.107/s1921-0289-2
21. Taiwan National Health Insurance Research Database. Introduction to the National Health Insurance Research Database. http://w3.nhri. org.tw/nhird/date-01.html. Accessed April 29, 2015.
22. Chang YC, Chou YJ, Liu JY, et al. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan-a representative population-based comparative study. J Infect. 2012;65(3):231-238. doi:10.016/jinf.2024.014 PubMed
23. Wang MT, Su CY, Chan AL, et al. Risk of digoxin intoxication in heart failure patients exposed to digoxin-diuretic interactions: a population-based study. Br J Clin Pharmacol. 2010;70(2):258-267. doi:10.1111/j.1365-25.201.03687.x PubMed
24. Wang MT, Tsai CL, Lo YW, et al. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study. Int J Cardiol. 2012;158(2):279-284. doi:10.1016/.ijcard.012.012 PubMed
25. Kang JH, Xirasagar S, Lin HC. Lower mortality among stroke patients with schizophrenia: a nationwide population-based study. Psychosom Med. 2011; 73 (1): 106-111. doi:10.1097/PSY.b01e381fd2c9 PubMed
26. Shen HN, Lu CL. Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: a nationwide population-based study in Taiwan. Pancreas. 2011;40(1):10-15. doi:10.1097/MPA.0b01e381fe750 PubMed
27. Lien HM, Chou SY, Liu JT. Hospital ownership and performance: evidence from stroke and cardiac treatment in Taiwan. J Health Econ. 2008;27(5):1208-1223. doi:10.1016/.jhealeco.283.002 PubMed
28. Shelton RC. Steps following attainment of remission: Discontinuation of antidepressant therapy. Prim Care Companion J Clin Psychiatry. 2001;3(4):168-174. doi:10.4088/PC.v3n0404 PubMed
29. Valuck RJ, Orton HD, Libby AM. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psychiatry. 2009;70(8):1069-1077. doi:10.408/JCP.08m0943 PubMed
30. Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be har med." BMJ. 2000;320(7233):503-506. doi:10.136/bmj320.723.503 PubMed
31. Tadrous M, Gagne JJ, Stürmer T, et al. Disease risk score as a confounder summary method: systematic review and recommendations. Pharmacoepidemiol Drug Saf. 2013;22(2):122-129. doi:10.102/pds.337 PubMed
32. Shin D, Oh YH, Eom CS, et al. Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. J Neurol. 2014;261(4):686-695. doi:10.17/s0415-04-7251-9 PubMed
33. Mead GE, Hsieh CF, Lee R, et al. Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke. 2013;44(3):844-850. doi:10.61/STROKEAHA12.63947 PubMed
34. Chollet F, Tardy J, Albucher JF, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10(2):123-130. doi:10.016/S147-42()70314-8 PubMed
35. Lee YC, Lin CH, Lin MS, et al. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study. J Clin Psychopharmacol. 2013;33(6):782-789. doi:10.1097/JCP.b013e31829c970e PubMed
36. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22(8): 983-988. doi:10.16/01.STR28.983 PubMed
37. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003; 361(9358): 653-661. doi:10.16/S0140-6736(03)1259-8 PubMed
38. Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-197. doi:10.2165/00018-2012403-003 PubMed
39. McMahon TC. A clinical overview of syndromes following withdrawal of antidepressants. Hosp Community Psychiatry. 1986;37(9):883-884. PubMed
40. Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236-241. doi:10.136/emj.184.236 PubMed
41. Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev. 2005;24(3):205-214. doi:10.2165/01379-2052403-013PubMed
42. Furukawa T, McGuire H, Barbui C. Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev. 2003; (3):C D003197. PubMed
43. Tatsumi M, Groshan K, Blakely RD, et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340(2-3): 249-258. doi:.106/S014-29 (7)01393-9 Pub Med
44. Sanglier T, Saragoussi D, Milea D, et al. Comparing antidepressant treatment patterns in older and younger adults: a claims database analysis. J Am Geriatr Soc. 2011;59(7):1197-1205. doi:10.1/j.1532-415.201.03457.xPubMed
45. Sundell KA, Gissler M, Petzold M, et al. Antidepressant utilization patterns and mortality in Swedish men and women aged 20-34 years. Eur J Clin Pharmacol. 2011;67(2):169-178. doi:10.107/s0281-093-z PubMed
46. Abbing-Karahagopian V, Huerta C, Souverein PC, et al. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. 2014;70(7):849-857. doi:10.17/s028-014176-z PubMed
47. Cheng CL, Kao YH, Lin SJ, et al. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236-242. doi:10.102/pds.2087PubMed
48. Toschke AM, Gulliford MC, Wolfe CD, et al. Antihypertensive treatment after first stroke in primary care: results from the General Practitioner Research Database. J Hypertens. 2011;29(1):154-160. doi:10.1097/JH.0b013e328f3897 PubMed
49. Schwamm LH, Fonarow GC, Reeves MJ, et al. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009;119 (1):107-115. do i:0.61/IRCU LATION HA.108.73688 PubMed